Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.

Kojima, T.; Shah, M.; Muro, K.; François, E.; Adenis, A.; Hsu, Chih-Hung; Doi, T.; Moriwaki, T.; Kim, Sung-Bae; Lee, Se-Hoon; Bennouna, J.; Kato, Ken; Shen, L.; Enzinger, P.; Qin, S.; Ferreira, P.; Chen, Jia; Girotto, G.; de la Fouchardière, C.; Sénellart, H.; Al-Rajabi, R.; Lordick, F.; Wang, Rui-xue; Suryawanshi, S.; Bhagia, P.; Kang, S.; Metges, J.

doi:10.1200/JCO.20.01888

Public

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.

Shared by NobleBlocks on Oct 7, 2020 • 12:00 AM UTC

Authors:

T. Kojima

M. Shah

K. Muro

Abstract

PURPOSE Patients with advanced esophageal cancer have a poor prognosis and limited treatment options after first-line chemotherapy. PATIENTS AND METHODS In this open-label, phase III study, we randomly assigned (1:1) 628 patients with advanced/metastatic squamous cell carcinoma or adenocarcinoma of ...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!